V
Vision Research Solutions | Philadelphia, PA
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
KSI-101
UBX1325
Aflibercept
Foselutoclax
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 4 total trials
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants with Macular Edema Secondary to Inflammation (MESI)
Enrolling
Macular Edema Secondary to Inflammation
Other: Sham Comparator
Drug: KSI-101
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants with Macular Edema Secondary to Inflammation (MESI)
Enrolling
Macular Edema Secondary to Inflammation
Drug: KSI-101
Other: Sham Comparator
A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants with Neovascular (...
Active, not recruiting
Wet Age-related Macular Degeneration
Drug: Tarcocimab tedromer
Drug: Aflibercept
Trial sponsors
U
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems